Results for tag: "Ankylosing Spondylitis Drug"

• 39 Results (Page 1 of 2)
• • Relevance 

    • Relevance
    • Published
    • Price
    Sort by Relevance Published Price

Ankylosing Spondylitis Market Research Report by Drug, Type of Molecule, Mechanism Of Action, Route Of Administration, Dosage Forms, End User, State - United States Forecast to 2027 - Cumulative Impact of COVID-19

•  Report
• April 2022
• 111 Pages

From

€2608EUR$2,654USD£2,238GBP

€2898EUR$2,949USD£2,487GBP

Saudi Arabia Ankylosing Spondylitis Drugs Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2027

•  Report
• February 2022
• 40 Pages

From

€2550EUR$2,595USD£2,188GBP

India Ankylosing Spondylitis Drugs Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2027

•  Report
• February 2022
• 40 Pages

From

€2550EUR$2,595USD£2,188GBP

Ankylosing Spondylitis Drugs Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2027

•  Report
• February 2022
• 100 Pages

From

€5105EUR$5,195USD£4,381GBP

Ankylosing Spondylitis (Bekhterev's Disease) - Epidemiology Forecast - 2032

•  Drug Pipelines
• February 2022
• 105 Pages

From

€3882EUR$3,950USD£3,331GBP

Ankylosing Spondylitis (AS) - Market Insights, Epidemiology, and Market Forecast - 2032

•  Report
• February 2022
• 210 Pages

From

€7370EUR$7,500USD£6,324GBP

Ankylosing Spondylitis - Market Insight, Epidemiology and Market Forecast -2032

•  Report
• January 2022
• 200 Pages

From

€7370EUR$7,500USD£6,324GBP

Ankylosing Spondylitis Market by Drug Class and Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2021-2030

•  Report
• January 2022
• 220 Pages

From

€6061EUR$6,168USD£5,201GBP

Ankylosing Spondylitis Market, by Drug Type, by Route of Administration, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 20201- 2028

•  Report
• December 2021
• 190 Pages

From

€3538EUR$3,600USD£3,036GBP

€4422EUR$4,500USD£3,795GBP

Global Ankylosing Spondylitis Market and Competitive Landscape - 2021

•  Report
• August 2021

From

€3921EUR$3,990USD£3,365GBP

Europe Ankylosing Spondylitis Market and Competitive Landscape - 2021

•  Report
• August 2021

From

€3361EUR$3,420USD£2,884GBP

Ankylosing Spondylitis - Pipeline Insight, 2021

•  Clinical Trials
• May 2021
• 80 Pages

From

€1965EUR$2,000USD£1,687GBP

Market Spotlight: Axial Spondyloarthritis (axSpA)

•  Report
• March 2021
• 52 Pages

€1295EUR$1,318USD£1,111GBP

Global Ankylosing Spondylitis Epidemiology and Patient Flow - 2021

•  Report
• February 2021

From

€2909EUR$2,960USD£2,496GBP

Ankylosing Spondylitis Market Share, Size, Trends, Industry Analysis Report, By Drug; By Treatment Type; By Regions; Segment Forecast, 2021 - 2028

•  Report
• February 2021
• 128 Pages

From

€4864EUR$4,950USD£4,174GBP

Global Ankylosing Spondylitis Clinical Trial Pipeline Highlights - 2021

•  Report
• January 2021

From

€973EUR$990USD£835GBP

US Ankylosing Spondylitis Market and Competitive Landscape - 2021

•  Report
• January 2021

From

€1739EUR$1,770USD£1,493GBP

Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline Review, H2 2020

•  Drug Pipelines
• November 2020
• 282 Pages

From

€1965EUR$2,000USD£1,687GBP

Ankylosing Spondylitis Treatment Market 2020-2026

•  Report
• July 2020

From

€5036EUR$5,125USD£4,322GBP

Global Axial Spondyloarthritis Treatment Market 2018-2022

•  Report
• October 2018
• 108 Pages

From

€2457EUR$2,500USD£2,108GBP

• 39 Results (Page 1 of 2)
• • 1
  • 2
  • 